Skip to main navigation Press Releases Year 2021 November 17, 2021 Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference SAN DIEGO , Nov. 17, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Piper Sandler 33 rd Annual Virtual Healthcare Conference . From November 22 nd to December 2 nd , presentations will be available November 10, 2021 Exagen Inc. Reports Third Quarter 2021 Results Quarterly Records: Ordering Healthcare Providers and Adopters SAN DIEGO , Nov. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2021 . November 4, 2021 Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum SAN DIEGO , Nov. 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum , which takes place November 18 th , 2021. October 27, 2021 Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021 SAN DIEGO , Oct. 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2021 after the market close on Wednesday, November 10, 2021 . October 27, 2021 Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus SAN DIEGO , Oct. 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® CTD and AVISE Lupus are a contracted covered service with Inland Empire Health Plan (IEHP), providing enhanced care to over 1.4 million members. October 25, 2021 Exagen Inc. Announces $27.2 Million Debt Refinancing SAN DIEGO , Oct. 25, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that it entered into an amendment to its loan and security agreement with its primary lender, an affiliate of Innovatus Capital Partners, LLC (“Innovatus”). October 21, 2021 Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021 SAN DIEGO , Oct. 21, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today it will be presenting new scientific research at the American College of Rheumatology’s (ACR) virtual annual meeting, ACR Convergence 2021. September 13, 2021 Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference SAN DIEGO , Sept. 13, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 27-30 th , 2021. August 9, 2021 Exagen Inc. Reports Second Quarter 2021 Results Quarterly Records: Total Revenue, AVISE® CTD Revenue and Volumes, Ordering Healthcare Providers and Adopters SAN DIEGO , Aug. 09, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, July 30, 2021 Exagen Appoints Ana Hooker to Board of Directors SAN DIEGO , July 30, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional independent member to its Board of Directors, effective July 29, 2021 . “We are excited to welcome Ms. Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last » Displaying 1 - 10 of 31 Print Page Email Alerts RSS Feeds Investor Contacts © 2021 Exagen Inc. | All Rights Reserved SA1168 Footer